#United States #Stuart #Edison Award #Quantum Detection #Base Molecular

Base Molecular Resonance™ Technologies' Recognition

In a significant milestone for the realm of science and technology, Base Molecular Resonance™ Technologies (BMRT) has received a nomination for the prestigious 2026 Edison Award. This recognition highlights their groundbreaking work in quantum resonance detection technology, which promises to revolutionize the way diseases, elements, and potential threats are identified.

The innovative Base Molecular Resonance™ (BMR™) technology is capable of non-invasively detecting molecular signatures associated with every element on the periodic table, over 200 types of cancer, and high-threat substances such as explosives and narcotics. What sets this technology apart is its ability to provide instant, safe results from both close and long distances, potentially transforming global protocols in crucial sectors like healthcare, national defense, and public safety.

A New Era of Detection Technology

BMRT's cutting-edge technology arrived after nearly four decades of advancement, paralleling efforts made by other significant innovators such as Nvidia, SpaceX, and Tesla, who are previous Edison Award recipients. Robert "Bo" Short, Co-Founder and CEO of BMRT, expressed his gratitude for the nomination, emphasizing that the company’s mission has always been to enhance lives by detecting diseases early and increasing safety on a global scale.

"Our goal is to save lives, to identify cancerous conditions before they manifest symptoms, and to avert violent incidents before they escalate," said Short. "This nomination is a meaningful step in achieving that vision. It reflects the unwavering dedication of our team and the support of our investors."

Unmatched Accuracy in Detection

BMRT's technological advancements have undergone rigorous testing and validation by the Centre for Applied Innovation at York St. John University in England. The results of these tests showcased an exceptional 100% accuracy rate, with no false positives or negatives reported, underscoring the reliability of the BMR™ technology.

Currently, the company holds 20 patents related to its innovations and boasts an impressive independent intellectual property valuation of $60.3 billion, spanning 56 global applications. This extensive portfolio underlines BMRT's leadership in the quantum physics landscape and its commitment to advancing detection methods.

Safety and Innovation

Co-Founder and President of BMRT, Lee Duke, highlighted that true innovation is measured not just by new discoveries but by the positive changes those discoveries bring to everyday life. "This recognition from the Edison Awards encapsulates years of meticulous research and a resolute aim to ensure safety and health in our communities. The effectiveness of our BMR™ technology marks a pivotal moment in public health and safety protocols," Duke said.

The winners of the 2026 Edison Awards are set to be announced in April 2026, an event the BMRT team eagerly anticipates as a celebration of their hard work and groundbreaking achievements in detection technology.

For more details about BMRT and its transformative technology, visit their website at www.BMRT.io.

Contact Information

Investment inquiries can be directed to Robert 'Bo' Short, CEO, at [email protected] For media inquiries, contact Bryan Adams, Chief Marketing Officer, at [email protected]